The current status and future perspectives of bariatric and metabolic surgery in the management of obesity and its co-morbidities.
10.3760/cma.j.cn112139-20211118-00540
- VernacularTitle:用于肥胖及其相关代谢代谢性疾病的主要减重代谢手术方式发展现状
- Author:
Gan Bin LI
1
;
Zhen Jun WANG
1
;
Jia Gang HAN
1
Author Information
1. Department of General Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China.
- Publication Type:Journal Article
- MeSH:
Bariatric Surgery;
Gastrectomy;
Gastric Balloon;
Gastric Bypass;
Humans;
Laparoscopy;
Morbidity;
Obesity/surgery*;
Obesity, Morbid/surgery*
- From:
Chinese Journal of Surgery
2022;60(2):188-192
- CountryChina
- Language:Chinese
-
Abstract:
Bariatric-metabolic surgery (BMS) has the potential of decreasing body weight and improving obesity-related metabolic syndrome by restricting food intake and malabsorption. Laparoscopic sleeve gastrectomy, Roux-en-Y gastric bypass, adjustable gastric banding, biliopancreatic diversion with duodenal switch are four major BMS procedures. Sleeve plus surgery, one-anastomosis gastric bypass, intragastric balloon and endoscopic surgery are also arising and gaining popularity due to their specific efficacy. Currently, BMS is now experiencing an era with deeply integrated interdisciplinarity, optimizing and innovating of surgeries and well-illustrated clinical efficacy, as a result, more obese patients would benefit from BMS.
